Atlas Trials

A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine.

Clinical trial NCT02052726 · COMPLETED

Trial details

NCT number
NCT02052726
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Clostridium Difficile
Start date
2014-01-22
Primary completion
2015-05-02
Enrollment
184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.